Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane M Da Silva

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
JAMA Oncology|November 28, 2019
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical CancerJyoti S Mayadev, Danielle Enserro, Yvonne G Lin, et al.
The Journal of General Virology|November 12, 2015
Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infectionJoseph G Skeate, Tania B Porras, Andrew W Woodham, et al.
Gynecologic Oncology|August 9, 2018
Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factorsLuana L S Rodrigues, Mariza G Morgado, Vikrant V Sahasrabuddhe, et al.
Papillomavirus Research (Amsterdam, Netherlands)|December 15, 2015
Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:CDiane M Da Silva, Andrew W Woodham, Laurie K Rijkee, et al.
Cancer Immunology Research|May 25, 2018
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune ResponsesAndrew W Woodham, Ross W Cheloha, Jingjing Ling, et al.
BMC Cancer|October 13, 2018
Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective studyLaurie L Brunette, Paulette Y Mhawech-Fauceglia, Lingyun Ji, et al.
Archives of Gynecology and Obstetrics|August 15, 2021
Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpointsErin A Blake, Malcolm S Ross, Megan E Ross, et al.
Cancer Immunology Research|April 17, 2020
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future TumorsGreta Garrido, Brett Schrand, Agata Levay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)Diane M Da Silva, Danielle M Enserro, Jyoti S Mayadev, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
Cancer|November 18, 2009
Phase 2 trial of combination thalidomide plus temozolomide in patients with metastatic malignant melanoma: Southwest Oncology Group S0508Joseph I Clark, James Moon, Laura F Hutchins, et al.
JAMA Oncology|November 28, 2019
Sequential Ipilimumab After Chemoradiotherapy in Curative-Intent Treatment of Patients With Node-Positive Cervical CancerJyoti S Mayadev, Danielle Enserro, Yvonne G Lin, et al.
The Journal of General Virology|November 12, 2015
Herpes simplex virus downregulation of secretory leukocyte protease inhibitor enhances human papillomavirus type 16 infectionJoseph G Skeate, Tania B Porras, Andrew W Woodham, et al.
Gynecologic Oncology|August 9, 2018
Cervico-vaginal self-collection in HIV-infected and uninfected women from Tapajós region, Amazon, Brazil: High acceptability, hrHPV diversity and risk factorsLuana L S Rodrigues, Mariza G Morgado, Vikrant V Sahasrabuddhe, et al.
Papillomavirus Research (Amsterdam, Netherlands)|December 15, 2015
Human papillomavirus-exposed Langerhans cells are activated by stabilized Poly-I:CDiane M Da Silva, Andrew W Woodham, Laurie K Rijkee, et al.
Cancer Immunology Research|May 25, 2018
Nanobody-Antigen Conjugates Elicit HPV-Specific Antitumor Immune ResponsesAndrew W Woodham, Ross W Cheloha, Jingjing Ling, et al.
BMC Cancer|October 13, 2018
Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective studyLaurie L Brunette, Paulette Y Mhawech-Fauceglia, Lingyun Ji, et al.
Archives of Gynecology and Obstetrics|August 15, 2021
Immunohistochemical analysis of glassy cell carcinoma of the cervix reveals robust lymphocyte infiltrate and the expression of targetable inhibitory immune checkpointsErin A Blake, Malcolm S Ross, Megan E Ross, et al.
Cancer Immunology Research|April 17, 2020
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future TumorsGreta Garrido, Brett Schrand, Agata Levay, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 21, 2020
Immune Activation in Patients with Locally Advanced Cervical Cancer Treated with Ipilimumab Following Definitive Chemoradiation (GOG-9929)Diane M Da Silva, Danielle M Enserro, Jyoti S Mayadev, et al.
Pageof 7